Health News


Researchers find that multiple children's deaths could be linked to teething tablets. So far ten deaths have been linked to children using homeopathic teething tablets. The U.S. Food and Drug Administration has also linked "400 adverse events" associated with the tablets. Parents with teething babies have been warned by the FDA to "stop using the products . . ."
foster-children-101816.jpg A new study shows that children in foster care are at higher risks of diseases. The study was conducted by Kristin Turney and Julie Steel and it was published in Health Daily News. Some of the identified risks included, mental health issues, ADHD, obesity, asthma, and depression to name a few. The study compared foster children to low-income and single parent families.
duster-091516.jpg As much as 45 toxic chemicals can be found in everyday common house dust, according to a new study. The new study, which saw researchers analyze all studies that have sampled indoor environments in the United States since 2000, found that the chemicals found in dust samples came from a range of things typically found inside your home, including vinyl products, such as flooring and cosmetics. More

Using Snus May Increase Risk Of Prostate Cancer

A new study suggests that the use of smokeless tobacco, or snus, may increase the risk of death in those with prostate cancer. The study, published in the International Journal of Cancer, found that those who used snus but did not smoke were three times more likely to die from prostate cancer than those who never used tobacco. For the study, researchers analyzed health check-up data.

Follow RTT
FDA Calendar
Event DateSymbolDrug NameEvent Name
01/07/17ANACCrisaborole topical ointment, 2% (NDA)FDA decision on Crisaborole for treatment of mild-to-moderate atopic dermatitis in children and adults.
01/03/17VCELMACI (BLA)FDA decision on MACI for the treatment of symptomatic cartilage defects of the knee in adult patients
12/28/16RHHBYOCREVUS (BLA)FDA decision on OCREVUS for the treatment of relapsing multiple sclerosis and primary progressive multiple sclerosis
12/28/16AAAPLutathera (NDA)FDA decision on Lutathera for the treatment of gastro entero pancreatic neuroendocrine tumors
12/28/16CEMPSolithera IV (NDA)FDA decision on Solithera as a treatment for community-acquired bacterial pneumonia
12/27/16CEMPSolithera oral (NDA)FDA decision on Solithera as a treatment for community-acquired bacterial pneumonia
More FDA Calendar Data

FDA Device Approval
No Records Found
More FDA Device Approval Data